Glaukos Corporation is delighted to announce the appointment of Humza Butt to the position of Territory Manager, West London.
Haag-Streit UK (HS-UK) will undergo a planned reorganisational strategy which will result in sister-company John Weiss & Son’s integration within HS-UK on 1st January 2022.
Santen UK is delighted to announce that it is officially certified as a great place to work by the independent global authority on workplace culture, Great Place to Work®.
Cataract if left untreated can have a detrimental impact on patients’ quality of life.
Haag-Streit UK is pleased to announce the launch of the MR Q Combo in the UK.
Create a sterile field by fixing the caps direct to the ophthalmic microscope pupil distance adjustment handles.
Optegra is delighted to announce the appointment of Mr Maghizh Anandan as a Consultant Eye Surgeon at Optegra Eye Hospital Birmingham.
Collaboration between The Royal College of Ophthalmologists and Bausch + Lomb ensures access to latest cutting-edge equipment for phaco surgery
Bausch + Lomb, a leading innovator in eye health, and The Royal College of Ophthalmologists (RCOphth.) announce a multi-year collaboration to ensure that trainees and experienced surgeons have access to the latest, cutting-edge equipment as part of simulation training for cataract and retinal surgery.
Glaukos Corporation is delighted to announce the appointment of Rachel Price to the position of Territory Manager, South Wales.
Positive outcomes for premium LuxSmart™ intraocular lenses, following one-year real-world experience
Bausch + Lomb’s premium lens designed for providing distance and intermediate continuous vision with a potentially similar dysphotopsia profile as a monofocal, thanks to its Pure Refractive Optics technology Bausch + Lomb today announced positive outcomes following the one-year real-world evaluation of its premium LuxSmart™ lens, since its European launch in 2020.
Théa Pharmaceuticals is excited to announce the launch of the Théa Academy, a dedicated platform supporting the education of eye health professionals across the UK.
Unlike other MIGS which create artificial flow, iTrack™ is a stent-free, tissue-sparing procedure that treats 360° of the conventional outflow pathway to re-establish natural aqueous flow.